Japan, March 26 -- ARO BIOTHERAPEUTICS COMPANY has got intellectual property rights for 'CD71 BINDING FIBRONECTIN TYPE III DOMAINS.' Other related details are as follows:
Application Number: JP,2024-200227
Category (FI): A61K31/4375,A61K31/7088,A61K31/7105,A61K31/711,A61K31/713,A61K38/08,A61K38/39,A61K39/395@L,A61K39/395@N,A61K39/395@W,A61K39/395@Y,A61K45/00,A61K47/60,A61K47/62,A61K47/68,A61K48/00,A61K49/00,A61K49/16,A61K51/10,200,A61P21/00,A61P25/00,A61P25/08,A61P25/16,A61P25/28,A61P3/10,A61P31/18,A61P35/00,A61P37/04,A61P9/10,A61P9/12,C07K14/78,C07K16/28,C07K16/42,C07K19/00,C12N1/15,C12N1/19,C12N1/21,C12N15/12,C12N15/62@Z,C12N15/63@Z,C12N5/10,C12P21/02@C,G01N33/574@A,G01N33/574@D,G01N33/57505,G01N33/5751,G01N33/57515,G01N33/5752,G01N33/5...